To Evaluate the Effect of Immune Checkpoint Inhibitors on Bladder Cancer: Efficacy, Safety and Prognostic of Geriatrics

被引：0
|
作者：
Zhang, Chuan [1 ]
Wang, Hao [1 ]
Li, Yue [2 ]
Zhang, Li [1 ]
Wang, Kai [1 ]
Liu, Hao [1 ]
Hu, Fugui [1 ]
机构：
[1] Chengdu Univ Chinese Tradit Med, Dept Urol, Chengdu Peoples Hosp 5, Chengdu, Peoples R China
[2] Chengdu Univ Chinese Tradit Med, Dept Qual Control, Chengdu Peoples Hosp 5, Chengdu, Peoples R China
来源：
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | 2021年 / 128卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
0208
引用
收藏
页码：9 / 10
页数：2
相关论文
共 50 条
  • [31] Efficacy and safety of immune checkpoint inhibitors in colorectal cancer: a systematic review and meta-analysis
    Tianni Zeng
    Xiaojie Fang
    Jinhua Lu
    Yazhen Zhong
    Xianlei Lin
    Zechen Lin
    Nan Wang
    Jing Jiang
    Shengyou Lin
    International Journal of Colorectal Disease, 2022, 37 : 251 - 258
  • [32] Efficacy and safety of Immune Checkpoint Inhibitors in Lung Cancer Patients with Combined Pulmonary Fibrosis and Emphysema
    Chin, Haruka
    Inomata, Minoru
    Sakamoto, Keita
    Ito, Ken
    Misumi, Akari
    Maeda, Takashi
    Ito, Yu
    Awano, Nobuyasu
    Kuse, Naoyuki
    Izumo, Takehiro
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [33] The Impact of FGFR3 Alterations on the Tumor Microenvironment and the Efficacy of Immune Checkpoint Inhibitors in Bladder Cancer
    Komura, Kazumasa
    Hirosuna, Kensuke
    Tokushige, Satoshi
    Tsujino, Takuya
    Nishimura, Kazuki
    Ishida, Mitsuaki
    Hayashi, Takuo
    Ura, Ayako
    Ohno, Takaya
    Yamazaki, Shogo
    Nakamori, Keita
    Kinoshita, Shoko
    Maenosono, Ryoichi
    Ajiro, Masahiko
    Yoshikawa, Yuki
    Takai, Tomoaki
    Tsutsumi, Takeshi
    Taniguchi, Kohei
    Tanaka, Tomohito
    Takahara, Kiyoshi
    Konuma, Tsuyoshi
    Inamoto, Teruo
    Hirose, Yoshinobu
    Ono, Fumihito
    Shiraishi, Yuichi
    Yoshimi, Akihide
    Azuma, Haruhito
    MOLECULAR CANCER, 2023, 22 (01)
  • [34] The Impact of FGFR3 Alterations on the Tumor Microenvironment and the Efficacy of Immune Checkpoint Inhibitors in Bladder Cancer
    Kazumasa Komura
    Kensuke Hirosuna
    Satoshi Tokushige
    Takuya Tsujino
    Kazuki Nishimura
    Mitsuaki Ishida
    Takuo Hayashi
    Ayako Ura
    Takaya Ohno
    Shogo Yamazaki
    Keita Nakamori
    Shoko Kinoshita
    Ryoichi Maenosono
    Masahiko Ajiro
    Yuki Yoshikawa
    Tomoaki Takai
    Takeshi Tsutsumi
    Kohei Taniguchi
    Tomohito Tanaka
    Kiyoshi Takahara
    Tsuyoshi Konuma
    Teruo Inamoto
    Yoshinobu Hirose
    Fumihito Ono
    Yuichi Shiraishi
    Akihide Yoshimi
    Haruhito Azuma
    Molecular Cancer, 22
  • [35] Efficacy and safety of immune checkpoint inhibitors in young adults with metastatic melanoma
    Wong, Selina K.
    Blum, Steven M.
    Sun, Xiaopeng
    Silva, Ines P. Da
    Zubiri, Leyre
    Ye, Fei
    Bai, Kun
    Zhang, Kevin
    Ugurel, Selma
    Zimmer, Lisa
    Livingstone, Elisabeth
    Schadendorf, Dirk
    Serra-Bellver, Patricio
    Munoz-Couselo, Eva
    Ortiz, Carolina
    Lostes, Julia
    Huertas, Roberto M.
    Arance, Ana
    Pickering, Lisa
    V. Long, Georgina
    Carlino, Matteo S.
    Buchbinder, Elizabeth I.
    Vazquez-Cortes, Leticia
    Jara-Casas, Diego
    Marquez-Rodas, Ivan
    Gonzalez-Espinoza, Ivan R.
    Balko, Justin M.
    Menzies, Alexander M.
    Sullivan, Ryan J.
    Johnson, Douglas B.
    EUROPEAN JOURNAL OF CANCER, 2023, 181 : 188 - 197
  • [36] Safety and efficacy of concurrent immune checkpoint inhibitors and hypofractionated body radiotherapy
    Mohamad, Osama
    de Leon, Alberto Diaz
    Schroeder, Samuel
    Leiker, Andrew
    Christie, Alana
    Zhang-Velten, Elizabeth
    Trivedi, Lakshya
    Khan, Saad
    Desai, Neil B.
    Laine, Aaron
    Albuquerque, Kevin
    Iyengar, Puneeth
    Arriaga, Yull
    Courtney, Kevin
    Gerber, David E.
    Hammers, Hans
    Choy, Hak
    Timmerman, Robert
    Brugarolas, James
    Hannan, Raquibul
    ONCOIMMUNOLOGY, 2018, 7 (07):
  • [37] Immune Checkpoint Inhibitors and Vaccination: Assessing Safety, Efficacy, and Synergistic Potential
    New, Jacob
    Shenton, Luke
    Ksayer, Radia
    Wang, Justin
    Zakharia, Karam
    Nicholson, Laura J.
    Pandey, Amitabh C.
    VACCINES, 2024, 12 (11)
  • [38] Efficacy and safety of immune checkpoint inhibitors in patients with advanced intrahepatic cholangiocarcinoma
    Peng, Ziting
    Dong, Jianhui
    Tang, Shuyao
    Shi, Jiaxu
    Shi, Tongdong
    FRONTIERS IN ONCOLOGY, 2025, 15
  • [39] Safety, efficacy, and tolerability of immune checkpoint inhibitors in the treatment of hepatocellular carcinoma
    Brown, Zachary J.
    Gregory, Stephanie
    Hewitt, D. Brock
    Iacono, Stephen
    Choe, Jennie
    Labiner, Hanna E.
    Pawlik, Timothy M.
    SURGICAL ONCOLOGY-OXFORD, 2022, 42
  • [40] Cancer cachexia reduces the efficacy of immune checkpoint inhibitors in cancer patients
    Yu, Yean
    Yan, Li
    Huang, Tianhui
    Wu, Zhenfu
    Liu, Juan
    AGING-US, 2024, 16 (06): : 5354 - 5369
12345